S. Veitch, M. S. Njock, M. Chandy, M. A. Siraj, L. Chi, H. Mak, K. Yu, K. Rathnakumar, C. A. Perez-Romero, Z. Chen, F. J. Alibhai, D. Gustafson, S. Raju, R. Wu, D. Z. Khat, Y. Wang, A. Caballero, P. Meagher, E. Lau, L. Pepic, H. S. Cheng, N. J. Galant, K. L. Howe, R. K. Li, K. A. Connelly, M. Husain, P. Delgado-Olguin, and J. E. Fish. MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes. Cardiovasc Diabetol, volume 21, issue 1, pages 31, February 2022.